Top of page

Student/Staff Portal
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation
You are here: Main Content

Related Contents

    • Dr Papanin Putsathit
      https://www.ecu.edu.au/__data/assets/image/0011/815618/papanin-putsathit.jpg
    • Dr Papanin Putsathit

      Dr Papanin Putsathit

  • See Also
  • Google Scholar profile
    https://scholar.google.com/citations?view_op=list_works&hl=en&authuser=4&user=JT-8eyAAAAAJ
  • Google Scholar profile
  • ResearchGate profile
    https://www.researchgate.net/profile/Papanin_Putsathit
  • ResearchGate profile
  • LinkedIn profile
    https://www.linkedin.com/in/papanin-putsathit-02b65774/
  • LinkedIn profile

Dr Papanin Putsathit

Post Doctoral Research Fellow

Staff Member Details
Email: p.putsathit@ecu.edu.au
ORCID iD: https://orcid.org/0000-0001-9789-4239

Papanin is an early career researcher working with Professor Thomas Riley's Clostridium difficile research group located in PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre. Her research focuses on the molecular epidemiology and antimicrobial susceptibility of C. difficile in humans, livestock and the environment, and on as assessing the effectiveness of novel compounds against C. difficile. The overarching aims of her career are to deepen our understanding of the epidemiology of pathogens like C. difficile and identify better ways to manage and treat the related infection.

Professional Associations

  • Australian Society for Microbiology

Awards and Recognition

  • UWA Scholarship for International Research Fees, 2013-2017
  • Australian Society for Microbiology Vacation Scholarship, 2010
  • Tuart College International Student Scholarship, 2007

Research Areas and Interests

Epidemiology of Clostridium difficile infection Antibiotic susceptibility One Health

Qualifications

  • Graduate Diploma of Education Secondary, Edith Cowan University, 2017.
  • Doctor of Philosophy, The University of Western Australia, 2017.
  • Bachelor of Science with Second Class Honours (Microbiology), The University of Western Australia, 2012.
  • Bachelor of Science (Biomedical Science), The University of Western Australia, 2011.

Research Outputs

2024

Journal Articles

  • O'Grady, K., Hong, S., Putsathit, P., George, N., Hemphill, C., Huntington, PG., Korman, TM., Kotsanas, D., Lahra, M., McDougall, R., McGlinchey, A., Levy, A., Moore, CV., Nimmo, G., Prendergast, L., Robson, J., Speers, DJ., Waring, L., Wehrhahn, MC., Weldhagen, GF., Wilson, RM., Riley, T., Knight, DR. (2024). Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia. Microbial Genomics, 10(5), article number 1232. https://doi.org/10.1099/mgen.0.001232.

2023

Journal Articles

  • Chisholm, JM., Putsathit, P., Riley, T., Lim, SC. (2023). Spore-Forming Clostridium (Clostridioides) Difficile In Wastewater Treatment Plants In Western Australia. Microbiology Spectrum, 11(1), 1-11 pp. https://doi.org/10.1128/spectrum.03582-22.
  • Knight, DR., Imwattana, K., Collins, D., Lim, S., Hong, S., Putsathit, P., Riley, T. (2023). Genomic Epidemiology And Transmission Dynamics Of Recurrent Clostridioides Difficile Infection In Western Australia. European Journal of Clinical Microbiology and Infectious Diseases, 42(5), 607-619. https://doi.org/10.1007/s10096-023-04569-x.

2022

Journal Articles

  • Haines, R., Putsathit, P., Tai, A., Hammer, K. (2022). Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm-forming multidrug-resistant cystic fibrosis-associated Pseudomonas aeruginosa as a single agent and in combination with commonly nebulized antibiotics. Letters in Applied Microbiology, 75(3), 578-587. https://doi.org/10.1111/lam.13589.
  • Imwattana, K., Putsathit, P., Collins, D., Leepattarakit, T., Kiratisin, P., Riley, T., Knight, D. (2022). Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017. Microbial Genomics, 8(3), Article Number 000792. https://doi.org/10.1099/mgen.0.000792.
  • Lim, SC., Collins, D., Imwattana, K., Knight, D., Perumalsamy, S., Hain-Saunders, N., Putsathit, P., Speers, D., Riley, T. (2022). Whole-genome sequencing links Clostridium (Clostridioides) difficile in a single hospital to diverse environmental sources in the community. Journal of Applied Microbiology, 133(3), 1156-1168. https://doi.org/10.1111/jam.15408.
  • Haines, R., Putsathit, P., Hammer, K., Tai, A. (2022). Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa. Scientific Reports, 12(1), article number 16814. https://doi.org/10.1038/s41598-022-21101-x.
  • Pitcher, N., Harjani, J., Zhao, Y., Jin, J., Knight, D., Li, L., Putsathit, P., Riley, T., Carter, G., Baell, J. (2022). Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract. ACS Omega, 7(8), 6737-6759. https://doi.org/10.1021/acsomega.1c06294.
  • Lim, SC., Hain-Saunders, N., Imwattana, K., Putsathit, P., Collins, D., Riley, T. (2022). Genetically related Clostridium difficile from water sources and human CDI cases revealed by whole‐genome sequencing. Environmental Microbiology, 24(3), 1221-1230. https://doi.org/10.1111/1462-2920.15821.

2021

Journal Articles

  • Mahadari, M., Jennepalli, S., Tague, A., Putsathit, P., Hutton, M., Hammer, K., Knight, D., Riley, T., Lyras, D., Keller, P., Pyne, S. (2021). Cationic peptidomimetic amphiphiles having a n-aryl- or n-naphthyl-1,2,3-triazole core structure targeting clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo c. difficile infection model. Antibiotics, 10(8), Article number 913. https://doi.org/10.3390/antibiotics10080913.
  • Tague, A., Putsathit, P., Riley, T., Keller, P., Pyne, S. (2021). Positional isomers of biphenyl antimicrobial peptidomimetic amphiphiles. ACS Medicinal Chemistry Letters, 12(3), 413 - 419. https://doi.org/10.1021/acsmedchemlett.0c00611.
  • Putsathit, P., Hong, S., George, N., Hemphill, C., Huntington, P., Korman, T., Kotsanas, D., Lahra, M., McDougall, R., McGlinchey, A., Moore, C., Nimmo, G., Prendergast, L., Robson, J., Waring, L., Wehrhahn, M., Weldhagen, G., Wilson, R., Riley, T., Knight, D. (2021). Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015–18. Journal of Antimicrobial Chemotherapy, 76(7), 1815-1821. https://doi.org/10.1093/jac/dkab099.
  • Tai, A., Putsathit, P., Eng, L., Imwattana, K., Collins, D., Mulrennan, S., Riley, T. (2021). Clostridioides difficile colonisation and infection in a cohort of Australian adults with cystic fibrosis. Journal of Hospital Infection, 113(July 2021), 44-51. https://doi.org/10.1016/j.jhin.2021.03.018.
  • Imwattana, K., Putsathit, P., Knight, D., Kiratisin, P., Riley, T. (2021). Molecular Characterization of, and Antimicrobial Resistance in, Clostridioides difficile from Thailand, 2017–2018. Microbial Drug Resistance, 27(11), 1505-1512. https://doi.org/10.1089/mdr.2020.0603.

2020

Journal Articles

  • Lew, T., Putsathit, P., Sohn, KM., Wu, Y., Ouchi, K., Ishii, Y., Tateda, K., Riley, T., Collins, D. (2020). Antimicrobial susceptibilities of clostridium difficile isolates from 12 Asia-pacific countries in 2014 and 2015. Antimicrobial Agents and Chemotherapy, 64(7), Article number e00296-20. https://doi.org/10.1128/AAC.00296-20.
  • Imwattana, K., Putsathit, P., Leepattarakit, T., Kiratisin, P., Riley, T. (2020). Mild or Malign: Clinical Characteristics and Outcomes of Clostridium difficile Infection in Thailand. Journal of Clinical Microbiology, 58(9), Article number e01217-20. https://doi.org/10.1128/JCM.01217-20.
  • Hong, S., Putsathit, P., George, N., Hemphill, C., Huntington, P., Korman, T., Kotsanas, D., Lahra, M., McDougall, R., Moore, C., Nimmo, G., Prendergast, L., Robson, J., Waring, L., Wehrhahn, M., Weldhagen, G., Wilson, R., Riley, T., Knight, D. (2020). Laboratory-based surveillance of Clostridium difficile infection in Australian healthcare and community settings, 2013–2018. Journal of Clinical Microbiology, 58(11), Article number e01552-20. https://doi.org/10.1128/JCM.01552-20.
  • Imwattana, K., Knight, D., Kullin, B., Collins, D., Putsathit, P., Kiratisin, P., Riley, T. (2020). Antimicrobial resistance in Clostridium difficile ribotype 017. Expert Review of Anti-infective Therapy, 18(1), 17-25. https://doi.org/10.1080/14787210.2020.1701436.

2019

Journal Articles

  • Perumalsamy, S., Putsathit, P., Riley, T. (2019). High prevalence of Clostridium difficile in soil, mulch and lawn samples from the grounds of Western Australian hospitals. Anaerobe, 60(December 2019), Article number 102065. https://doi.org/10.1016/j.anaerobe.2019.06.018.
  • Putsathit, P., Neela, V., Joseph, N., Ooi, P., Ngamwongsatit, B., Knight, D., Riley, T. (2019). Molecular epidemiology of Clostridium difficile isolated from piglets. Veterinary Microbiology, 237(October 2019), Article 108408. https://doi.org/10.1016/j.vetmic.2019.108408.
  • Tague, A., Putsathit, P., Hammer, K., Wales, S., Knight, D., Riley, T., Keller, P., Pyne, S. (2019). Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies. European Journal of Medicinal Chemistry, 168(15 April 2019), 386-404. https://doi.org/10.1016/j.ejmech.2019.02.013.
  • Tague, A., Putsathit, P., Hutton, M., Hammer, K., Wales, S., Knight, D., Riley, T., Lyras, D., Keller, P., Pyne, S. (2019). Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model. European Journal of Medicinal Chemistry, 170(15 May 2019), 203-224. https://doi.org/10.1016/j.ejmech.2019.02.068.
  • Imwattana, K., Knight, D., Kullin, B., Collins, D., Putsathit, P., Kiratisin, P., Riley, T. (2019). Clostridium difficile ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia. Emerging Microbes and Infections, 8(1), 796-807. https://doi.org/10.1080/22221751.2019.1621670.

2017

Journal Articles

  • Putsathit, P., Maneerattanaporn, M., Piewngam, P., Knight, DR., Kiratisin, P., Riley, T. (2017). Antimicrobial susceptibility of Clostridium difficile isolated in Thailand. Antimicrobial Resistance and Infection Control, 6(2017), Article no. 58. https://doi.org/10.1186/s13756-017-0214-z.
  • Collins, D., Putsathit, P., Elliott, B., Riley, T. (2017). Laboratory-based surveillance of Clostridium difficile strains circulating in the Australian healthcare setting in 2012. Pathology, 49(3), 309-313. https://doi.org/10.1016/j.pathol.2016.10.013.
  • Putsathit, P., Maneerattanaporn, M., Piewngam, P., Kiratisin, P., Riley, T. (2017). Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand. New Microbes and New Infections, 15(n/a), 27-32. https://doi.org/10.1016/j.nmni.2016.10.004.

2016

Journal Articles

  • Knight, DR., Putsathit, P., Elliott, B., Riley, T. (2016). Contamination of Australian newborn calf carcasses at slaughter with Clostridium difficile. Clinical Microbiology and Infection, 22(3), 266.e1-266.e7. https://doi.org/10.1016/j.cmi.2015.11.017.
  • Moono, P., Putsathit, P., Knight, D., Squire, M., Hampson, D., Foster, N., Riley, T. (2016). Persistence of Clostridium difficile RT 237 infection in a Western Australian piggery. Anaerobe, 37(01), 62-66. https://doi.org/10.1016/j.anaerobe.2015.11.012.

2015

Journal Articles

  • Putsathit, P., Morgan, J., Bradford, D., Engelhardt, N., Riley, T. (2015). Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens. Pathology, 47(2), 165-168. https://doi.org/10.1097/PAT.0000000000000214.
  • Putsathit, P., Kiratisin, P., Ngamwongsatit, P., Riley, T. (2015). Clostridium difficile infection in Thailand. International Journal of Antimicrobial Agents, 45(1), 1-7. https://doi.org/10.1016/j.ijantimicag.2014.09.005.

2014

Journal Articles

  • Hart , J., Putsathit, P., Knight, D., Sammels, L., Riley, T., Keil, A. (2014). Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies. European Journal of Clinical Microbiology and Infectious Diseases: an international journal on pathogenesis, diagnosis, epidemiology, therapy, and prevention of infectious diseases, 33(9), 1555-1564. https://doi.org/10.1007/s10096-014-2108-9.

2013

Journal Articles

  • Knight, D., Thean, S., Putsathit, P., Fenwick, S., Riley, T. (2013). Cross-Sectional Study Reveals High Prevalence of Clostridium difficile Non-PCR Ribotype 078 Strains in Australian Veal Calves at Slaughter. Applied and Environmental Microbiology, 79(8), 2630-2635. https://doi.org/10.1128/AEM.03951-12.

Research Projects

  • Asymptomatic carriage of Clostridium difficile in adults in the Western Australian community, Edith Cowan University, ECU Early Career Researcher Grant - 2019, 2019 ‑ 2020, $26,604.

Research Student Supervision

Skip to top of page